StockDriftsStockDriftsSamsung Pharmaceutical (001360) has 0 disclosed insider purchases and 2 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩13M ($9K) in reported transaction value. The earliest filing StockDrifts holds for Samsung Pharmaceutical is dated 2024-02-23; the most recent is 2024-06-12. Across these filings the average return since disclosure is -28.76%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2024-06-12 | SELL | Market Sell | 전상일 Jeon Sang-il | moving | -5.0K | ₩1,604 | -30.3% | ₩8M ($6K) |
| 2024-05-28 | SELL | Market Sell | 전상일 Jeon Sang-il | moving | -3.0K | ₩1,643 | -27.2% | ₩5M ($3K) |
| 2024-04-30 | BUY | 신규보고 | 최영선 Choi Young-seon | Managing Director | 1.0K | ₩1,718 | +21.6% | ₩2M ($1K) |
| 2024-04-30 | BUY | 신규보고 | 전상일 Jeon Sang-il | moving | 12.2K | ₩1,718 | +21.6% | ₩21M ($15K) |
| 2024-02-23 | BUY | 유상신주취득 | 정경표 Jeong Kyung-pyo | moving | 1.4K | ₩2,200 | -5.0% | ₩3M ($2K) |
| 2024-02-23 | BUY | 유상신주취득 | 박봉권 Park Bong-kwon | Outside Director | 568 | ₩2,200 | -5.0% | ₩1M ($868) |
| 2024-02-23 | BUY | 유상신주취득 | 젬백스 Gemvax | - | 2.8M | ₩2,200 | -5.0% | ₩6.2B ($4.3M) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.